nodes	percent_of_prediction	percent_of_DWPC	metapath
Fondaparinux sodium—SERPINC1—Glypican 1 network—FLT1—melanoma	0.0138	0.0844	CbGpPWpGaD
Fondaparinux sodium—SERPINC1—Complement and Coagulation Cascades—CLU—melanoma	0.0104	0.0635	CbGpPWpGaD
Fondaparinux sodium—SERPINC1—Complement and Coagulation Cascades—F2R—melanoma	0.00789	0.0481	CbGpPWpGaD
Fondaparinux sodium—SERPINC1—Glypican 1 network—FGF2—melanoma	0.00619	0.0377	CbGpPWpGaD
Fondaparinux sodium—F10—Complement and Coagulation Cascades—CLU—melanoma	0.00588	0.0359	CbGpPWpGaD
Fondaparinux sodium—SERPINC1—Hemostasis—CEACAM1—melanoma	0.00449	0.0274	CbGpPWpGaD
Fondaparinux sodium—F10—Complement and Coagulation Cascades—F2R—melanoma	0.00446	0.0272	CbGpPWpGaD
Fondaparinux sodium—SERPINC1—Glypican 1 network—VEGFA—melanoma	0.0044	0.0268	CbGpPWpGaD
Fondaparinux sodium—F10—Post-translational protein modification—PIGU—melanoma	0.00421	0.0257	CbGpPWpGaD
Fondaparinux sodium—F10—Post-translational protein modification—ADAMTS20—melanoma	0.00421	0.0257	CbGpPWpGaD
Fondaparinux sodium—F10—Beta2 integrin cell surface interactions—ICAM1—melanoma	0.00396	0.0242	CbGpPWpGaD
Fondaparinux sodium—Dysphagia—Carmustine—melanoma	0.00314	0.00375	CcSEcCtD
Fondaparinux sodium—Alanine aminotransferase increased—Temozolomide—melanoma	0.00309	0.0037	CcSEcCtD
Fondaparinux sodium—Haematuria—Bleomycin—melanoma	0.00305	0.00365	CcSEcCtD
Fondaparinux sodium—Abdominal distension—Temozolomide—melanoma	0.00305	0.00365	CcSEcCtD
Fondaparinux sodium—Fluid retention—Docetaxel—melanoma	0.00305	0.00365	CcSEcCtD
Fondaparinux sodium—Dysphagia—Temozolomide—melanoma	0.00303	0.00363	CcSEcCtD
Fondaparinux sodium—Sweating increased—Temozolomide—melanoma	0.00295	0.00353	CcSEcCtD
Fondaparinux sodium—Decreased appetite—Vemurafenib—melanoma	0.00293	0.00351	CcSEcCtD
Fondaparinux sodium—Bronchitis—Temozolomide—melanoma	0.00291	0.00349	CcSEcCtD
Fondaparinux sodium—Gastrointestinal disorder—Vemurafenib—melanoma	0.00291	0.00348	CcSEcCtD
Fondaparinux sodium—Fatigue—Vemurafenib—melanoma	0.00291	0.00348	CcSEcCtD
Fondaparinux sodium—Haemoglobin—Bleomycin—melanoma	0.00289	0.00346	CcSEcCtD
Fondaparinux sodium—Constipation—Vemurafenib—melanoma	0.00288	0.00345	CcSEcCtD
Fondaparinux sodium—Haemorrhage—Bleomycin—melanoma	0.00288	0.00344	CcSEcCtD
Fondaparinux sodium—Lightheadedness—Docetaxel—melanoma	0.00287	0.00344	CcSEcCtD
Fondaparinux sodium—Hypoaesthesia—Bleomycin—melanoma	0.00286	0.00342	CcSEcCtD
Fondaparinux sodium—F10—Post-translational protein modification—SLC17A5—melanoma	0.00281	0.0171	CbGpPWpGaD
Fondaparinux sodium—Sepsis—Docetaxel—melanoma	0.00279	0.00333	CcSEcCtD
Fondaparinux sodium—Renal failure—Carmustine—melanoma	0.00275	0.00329	CcSEcCtD
Fondaparinux sodium—Urinary tract infection—Carmustine—melanoma	0.00272	0.00325	CcSEcCtD
Fondaparinux sodium—F10—Post-translational protein modification—ADAMTS13—melanoma	0.00271	0.0165	CbGpPWpGaD
Fondaparinux sodium—Phlebitis—Docetaxel—melanoma	0.00271	0.00324	CcSEcCtD
Fondaparinux sodium—Infestation NOS—Temozolomide—melanoma	0.0027	0.00323	CcSEcCtD
Fondaparinux sodium—Infestation—Temozolomide—melanoma	0.0027	0.00323	CcSEcCtD
Fondaparinux sodium—Flushing—Bleomycin—melanoma	0.00267	0.00319	CcSEcCtD
Fondaparinux sodium—Body temperature increased—Vemurafenib—melanoma	0.00267	0.00319	CcSEcCtD
Fondaparinux sodium—Swelling—Docetaxel—melanoma	0.00264	0.00316	CcSEcCtD
Fondaparinux sodium—Urinary tract infection—Temozolomide—melanoma	0.00263	0.00314	CcSEcCtD
Fondaparinux sodium—Cardiac failure congestive—Docetaxel—melanoma	0.00257	0.00308	CcSEcCtD
Fondaparinux sodium—Hepatobiliary disease—Temozolomide—melanoma	0.00256	0.00306	CcSEcCtD
Fondaparinux sodium—F10—Hemostasis—CEACAM1—melanoma	0.00254	0.0155	CbGpPWpGaD
Fondaparinux sodium—Haemoglobin—Carmustine—melanoma	0.00252	0.00302	CcSEcCtD
Fondaparinux sodium—Haemorrhage—Carmustine—melanoma	0.00251	0.003	CcSEcCtD
Fondaparinux sodium—Hypoaesthesia—Carmustine—melanoma	0.0025	0.00299	CcSEcCtD
Fondaparinux sodium—Hot flush—Docetaxel—melanoma	0.00249	0.00298	CcSEcCtD
Fondaparinux sodium—Flushing—Dactinomycin—melanoma	0.00249	0.00298	CcSEcCtD
Fondaparinux sodium—Hypersensitivity—Vemurafenib—melanoma	0.00248	0.00297	CcSEcCtD
Fondaparinux sodium—Oedema peripheral—Carmustine—melanoma	0.00247	0.00296	CcSEcCtD
Fondaparinux sodium—Menopausal symptoms—Docetaxel—melanoma	0.00247	0.00296	CcSEcCtD
Fondaparinux sodium—Atrial fibrillation—Docetaxel—melanoma	0.00246	0.00294	CcSEcCtD
Fondaparinux sodium—Renal impairment—Docetaxel—melanoma	0.00245	0.00293	CcSEcCtD
Fondaparinux sodium—Dermatitis bullous—Docetaxel—melanoma	0.00244	0.00292	CcSEcCtD
Fondaparinux sodium—Haemoglobin—Temozolomide—melanoma	0.00244	0.00292	CcSEcCtD
Fondaparinux sodium—Haemorrhage—Temozolomide—melanoma	0.00243	0.0029	CcSEcCtD
Fondaparinux sodium—Asthenia—Vemurafenib—melanoma	0.00242	0.00289	CcSEcCtD
Fondaparinux sodium—Hypoaesthesia—Temozolomide—melanoma	0.00241	0.00289	CcSEcCtD
Fondaparinux sodium—Oedema peripheral—Temozolomide—melanoma	0.00239	0.00286	CcSEcCtD
Fondaparinux sodium—Cardiac failure—Docetaxel—melanoma	0.00239	0.00286	CcSEcCtD
Fondaparinux sodium—Pruritus—Vemurafenib—melanoma	0.00239	0.00285	CcSEcCtD
Fondaparinux sodium—Pain in extremity—Docetaxel—melanoma	0.00233	0.00279	CcSEcCtD
Fondaparinux sodium—Flushing—Carmustine—melanoma	0.00233	0.00279	CcSEcCtD
Fondaparinux sodium—Anaemia—Bleomycin—melanoma	0.00231	0.00277	CcSEcCtD
Fondaparinux sodium—Diarrhoea—Vemurafenib—melanoma	0.00231	0.00276	CcSEcCtD
Fondaparinux sodium—Flushing—Temozolomide—melanoma	0.00225	0.00269	CcSEcCtD
Fondaparinux sodium—Arrhythmia—Carmustine—melanoma	0.00224	0.00268	CcSEcCtD
Fondaparinux sodium—Dizziness—Vemurafenib—melanoma	0.00223	0.00267	CcSEcCtD
Fondaparinux sodium—Angiopathy—Temozolomide—melanoma	0.0022	0.00263	CcSEcCtD
Fondaparinux sodium—SERPINC1—Hemostasis—BSG—melanoma	0.00219	0.0134	CbGpPWpGaD
Fondaparinux sodium—Immune system disorder—Temozolomide—melanoma	0.00219	0.00262	CcSEcCtD
Fondaparinux sodium—Mediastinal disorder—Temozolomide—melanoma	0.00219	0.00262	CcSEcCtD
Fondaparinux sodium—Malnutrition—Carmustine—melanoma	0.00219	0.00261	CcSEcCtD
Fondaparinux sodium—Cough—Bleomycin—melanoma	0.00218	0.00261	CcSEcCtD
Fondaparinux sodium—Dehydration—Docetaxel—melanoma	0.00217	0.00259	CcSEcCtD
Fondaparinux sodium—Anaemia—Dactinomycin—melanoma	0.00216	0.00258	CcSEcCtD
Fondaparinux sodium—Vomiting—Vemurafenib—melanoma	0.00214	0.00256	CcSEcCtD
Fondaparinux sodium—Chest pain—Bleomycin—melanoma	0.00213	0.00255	CcSEcCtD
Fondaparinux sodium—Rash—Vemurafenib—melanoma	0.00213	0.00254	CcSEcCtD
Fondaparinux sodium—SERPINC1—Hemostasis—IFNA5—melanoma	0.00213	0.013	CbGpPWpGaD
Fondaparinux sodium—Dermatitis—Vemurafenib—melanoma	0.00212	0.00254	CcSEcCtD
Fondaparinux sodium—Back pain—Carmustine—melanoma	0.00211	0.00253	CcSEcCtD
Fondaparinux sodium—Headache—Vemurafenib—melanoma	0.00211	0.00253	CcSEcCtD
Fondaparinux sodium—Malnutrition—Temozolomide—melanoma	0.00211	0.00253	CcSEcCtD
Fondaparinux sodium—Aspartate aminotransferase increased—Docetaxel—melanoma	0.0021	0.00251	CcSEcCtD
Fondaparinux sodium—Dysgeusia—Temozolomide—melanoma	0.00207	0.00247	CcSEcCtD
Fondaparinux sodium—SERPINC1—Hemostasis—FLNA—melanoma	0.00206	0.0126	CbGpPWpGaD
Fondaparinux sodium—Confusional state—Bleomycin—melanoma	0.00206	0.00246	CcSEcCtD
Fondaparinux sodium—Vision blurred—Carmustine—melanoma	0.00206	0.00246	CcSEcCtD
Fondaparinux sodium—Alanine aminotransferase increased—Docetaxel—melanoma	0.00206	0.00246	CcSEcCtD
Fondaparinux sodium—Anaphylactic shock—Bleomycin—melanoma	0.00204	0.00244	CcSEcCtD
Fondaparinux sodium—Oedema—Bleomycin—melanoma	0.00204	0.00244	CcSEcCtD
Fondaparinux sodium—Back pain—Temozolomide—melanoma	0.00204	0.00244	CcSEcCtD
Fondaparinux sodium—Infection—Bleomycin—melanoma	0.00203	0.00243	CcSEcCtD
Fondaparinux sodium—Anaemia—Carmustine—melanoma	0.00202	0.00242	CcSEcCtD
Fondaparinux sodium—Dysphagia—Docetaxel—melanoma	0.00202	0.00241	CcSEcCtD
Fondaparinux sodium—Nausea—Vemurafenib—melanoma	0.002	0.0024	CcSEcCtD
Fondaparinux sodium—Thrombocytopenia—Bleomycin—melanoma	0.002	0.00239	CcSEcCtD
Fondaparinux sodium—F10—Metabolism of proteins—PIGU—melanoma	0.002	0.0122	CbGpPWpGaD
Fondaparinux sodium—F10—Metabolism of proteins—ADAMTS20—melanoma	0.002	0.0122	CbGpPWpGaD
Fondaparinux sodium—Vision blurred—Temozolomide—melanoma	0.00199	0.00238	CcSEcCtD
Fondaparinux sodium—Bronchospasm—Docetaxel—melanoma	0.00198	0.00237	CcSEcCtD
Fondaparinux sodium—Anaemia—Temozolomide—melanoma	0.00195	0.00233	CcSEcCtD
Fondaparinux sodium—Anorexia—Bleomycin—melanoma	0.00195	0.00233	CcSEcCtD
Fondaparinux sodium—Angioedema—Temozolomide—melanoma	0.00193	0.00231	CcSEcCtD
Fondaparinux sodium—Hypotension—Bleomycin—melanoma	0.00191	0.00228	CcSEcCtD
Fondaparinux sodium—Oedema—Dactinomycin—melanoma	0.00191	0.00228	CcSEcCtD
Fondaparinux sodium—Vertigo—Temozolomide—melanoma	0.0019	0.00227	CcSEcCtD
Fondaparinux sodium—Convulsion—Carmustine—melanoma	0.00189	0.00226	CcSEcCtD
Fondaparinux sodium—Infection—Dactinomycin—melanoma	0.00189	0.00226	CcSEcCtD
Fondaparinux sodium—SERPINC1—Hemostasis—CLU—melanoma	0.00187	0.0114	CbGpPWpGaD
Fondaparinux sodium—Palpitations—Temozolomide—melanoma	0.00187	0.00223	CcSEcCtD
Fondaparinux sodium—Thrombocytopenia—Dactinomycin—melanoma	0.00187	0.00223	CcSEcCtD
Fondaparinux sodium—Chest pain—Carmustine—melanoma	0.00186	0.00223	CcSEcCtD
Fondaparinux sodium—Anxiety—Carmustine—melanoma	0.00185	0.00222	CcSEcCtD
Fondaparinux sodium—Cough—Temozolomide—melanoma	0.00184	0.0022	CcSEcCtD
Fondaparinux sodium—Paraesthesia—Bleomycin—melanoma	0.00183	0.00219	CcSEcCtD
Fondaparinux sodium—Convulsion—Temozolomide—melanoma	0.00183	0.00219	CcSEcCtD
Fondaparinux sodium—F10—Metabolism of proteins—ARL2—melanoma	0.00183	0.0111	CbGpPWpGaD
Fondaparinux sodium—SERPINC1—Hemostasis—RHOB—melanoma	0.00183	0.0111	CbGpPWpGaD
Fondaparinux sodium—Dyspnoea—Bleomycin—melanoma	0.00182	0.00218	CcSEcCtD
Fondaparinux sodium—Anorexia—Dactinomycin—melanoma	0.00182	0.00217	CcSEcCtD
Fondaparinux sodium—Confusional state—Carmustine—melanoma	0.0018	0.00215	CcSEcCtD
Fondaparinux sodium—Infestation—Docetaxel—melanoma	0.0018	0.00215	CcSEcCtD
Fondaparinux sodium—Infestation NOS—Docetaxel—melanoma	0.0018	0.00215	CcSEcCtD
Fondaparinux sodium—Anxiety—Temozolomide—melanoma	0.00179	0.00214	CcSEcCtD
Fondaparinux sodium—Unspecified disorder of skin and subcutaneous tissue—Temozolomide—melanoma	0.00179	0.00214	CcSEcCtD
Fondaparinux sodium—Oedema—Carmustine—melanoma	0.00178	0.00213	CcSEcCtD
Fondaparinux sodium—Decreased appetite—Bleomycin—melanoma	0.00178	0.00212	CcSEcCtD
Fondaparinux sodium—Infection—Carmustine—melanoma	0.00177	0.00212	CcSEcCtD
Fondaparinux sodium—Acute coronary syndrome—Docetaxel—melanoma	0.00177	0.00212	CcSEcCtD
Fondaparinux sodium—Renal failure—Docetaxel—melanoma	0.00177	0.00211	CcSEcCtD
Fondaparinux sodium—Myocardial infarction—Docetaxel—melanoma	0.00176	0.00211	CcSEcCtD
Fondaparinux sodium—Pain—Bleomycin—melanoma	0.00175	0.00209	CcSEcCtD
Fondaparinux sodium—Thrombocytopenia—Carmustine—melanoma	0.00175	0.00209	CcSEcCtD
Fondaparinux sodium—Tachycardia—Carmustine—melanoma	0.00174	0.00208	CcSEcCtD
Fondaparinux sodium—Confusional state—Temozolomide—melanoma	0.00174	0.00208	CcSEcCtD
Fondaparinux sodium—Anaphylactic shock—Temozolomide—melanoma	0.00172	0.00206	CcSEcCtD
Fondaparinux sodium—Oedema—Temozolomide—melanoma	0.00172	0.00206	CcSEcCtD
Fondaparinux sodium—Infection—Temozolomide—melanoma	0.00171	0.00205	CcSEcCtD
Fondaparinux sodium—Anorexia—Carmustine—melanoma	0.0017	0.00203	CcSEcCtD
Fondaparinux sodium—Hepatobiliary disease—Docetaxel—melanoma	0.0017	0.00203	CcSEcCtD
Fondaparinux sodium—Epistaxis—Docetaxel—melanoma	0.00169	0.00203	CcSEcCtD
Fondaparinux sodium—Nervous system disorder—Temozolomide—melanoma	0.00169	0.00202	CcSEcCtD
Fondaparinux sodium—Thrombocytopenia—Temozolomide—melanoma	0.00169	0.00202	CcSEcCtD
Fondaparinux sodium—Feeling abnormal—Bleomycin—melanoma	0.00168	0.00201	CcSEcCtD
Fondaparinux sodium—Skin disorder—Temozolomide—melanoma	0.00167	0.002	CcSEcCtD
Fondaparinux sodium—Hypotension—Carmustine—melanoma	0.00167	0.00199	CcSEcCtD
Fondaparinux sodium—Hyperhidrosis—Temozolomide—melanoma	0.00167	0.00199	CcSEcCtD
Fondaparinux sodium—Decreased appetite—Dactinomycin—melanoma	0.00166	0.00198	CcSEcCtD
Fondaparinux sodium—Fatigue—Dactinomycin—melanoma	0.00164	0.00197	CcSEcCtD
Fondaparinux sodium—Anorexia—Temozolomide—melanoma	0.00164	0.00197	CcSEcCtD
Fondaparinux sodium—SERPINC1—Hemostasis—RAC2—melanoma	0.00164	0.00997	CbGpPWpGaD
Fondaparinux sodium—Pain—Dactinomycin—melanoma	0.00163	0.00195	CcSEcCtD
Fondaparinux sodium—Urticaria—Bleomycin—melanoma	0.00162	0.00194	CcSEcCtD
Fondaparinux sodium—Haemoglobin—Docetaxel—melanoma	0.00162	0.00194	CcSEcCtD
Fondaparinux sodium—Body temperature increased—Bleomycin—melanoma	0.00162	0.00193	CcSEcCtD
Fondaparinux sodium—Haemorrhage—Docetaxel—melanoma	0.00161	0.00193	CcSEcCtD
Fondaparinux sodium—Insomnia—Carmustine—melanoma	0.00161	0.00193	CcSEcCtD
Fondaparinux sodium—SERPINC1—Hemostasis—VEGFC—melanoma	0.00161	0.00982	CbGpPWpGaD
Fondaparinux sodium—Hypoaesthesia—Docetaxel—melanoma	0.00161	0.00192	CcSEcCtD
Fondaparinux sodium—Paraesthesia—Carmustine—melanoma	0.0016	0.00192	CcSEcCtD
Fondaparinux sodium—Dyspnoea—Carmustine—melanoma	0.00159	0.0019	CcSEcCtD
Fondaparinux sodium—Oedema peripheral—Docetaxel—melanoma	0.00159	0.0019	CcSEcCtD
Fondaparinux sodium—Somnolence—Carmustine—melanoma	0.00159	0.0019	CcSEcCtD
Fondaparinux sodium—Feeling abnormal—Dactinomycin—melanoma	0.00157	0.00188	CcSEcCtD
Fondaparinux sodium—Insomnia—Temozolomide—melanoma	0.00156	0.00186	CcSEcCtD
Fondaparinux sodium—Gastrointestinal pain—Dactinomycin—melanoma	0.00156	0.00186	CcSEcCtD
Fondaparinux sodium—Decreased appetite—Carmustine—melanoma	0.00155	0.00185	CcSEcCtD
Fondaparinux sodium—Paraesthesia—Temozolomide—melanoma	0.00155	0.00185	CcSEcCtD
Fondaparinux sodium—Gastrointestinal disorder—Carmustine—melanoma	0.00154	0.00184	CcSEcCtD
Fondaparinux sodium—Dyspnoea—Temozolomide—melanoma	0.00154	0.00184	CcSEcCtD
Fondaparinux sodium—Somnolence—Temozolomide—melanoma	0.00153	0.00183	CcSEcCtD
Fondaparinux sodium—Pain—Carmustine—melanoma	0.00152	0.00182	CcSEcCtD
Fondaparinux sodium—Constipation—Carmustine—melanoma	0.00152	0.00182	CcSEcCtD
Fondaparinux sodium—Dyspepsia—Temozolomide—melanoma	0.00152	0.00181	CcSEcCtD
Fondaparinux sodium—Abdominal pain—Dactinomycin—melanoma	0.00151	0.0018	CcSEcCtD
Fondaparinux sodium—Body temperature increased—Dactinomycin—melanoma	0.00151	0.0018	CcSEcCtD
Fondaparinux sodium—Hypersensitivity—Bleomycin—melanoma	0.00151	0.0018	CcSEcCtD
Fondaparinux sodium—Decreased appetite—Temozolomide—melanoma	0.0015	0.00179	CcSEcCtD
Fondaparinux sodium—Flushing—Docetaxel—melanoma	0.0015	0.00179	CcSEcCtD
Fondaparinux sodium—Gastrointestinal disorder—Temozolomide—melanoma	0.00149	0.00178	CcSEcCtD
Fondaparinux sodium—Fatigue—Temozolomide—melanoma	0.00149	0.00178	CcSEcCtD
Fondaparinux sodium—Pain—Temozolomide—melanoma	0.00147	0.00176	CcSEcCtD
Fondaparinux sodium—Constipation—Temozolomide—melanoma	0.00147	0.00176	CcSEcCtD
Fondaparinux sodium—Feeling abnormal—Carmustine—melanoma	0.00147	0.00176	CcSEcCtD
Fondaparinux sodium—Asthenia—Bleomycin—melanoma	0.00147	0.00175	CcSEcCtD
Fondaparinux sodium—Angiopathy—Docetaxel—melanoma	0.00146	0.00175	CcSEcCtD
Fondaparinux sodium—Gastrointestinal pain—Carmustine—melanoma	0.00146	0.00174	CcSEcCtD
Fondaparinux sodium—Immune system disorder—Docetaxel—melanoma	0.00146	0.00174	CcSEcCtD
Fondaparinux sodium—Mediastinal disorder—Docetaxel—melanoma	0.00145	0.00174	CcSEcCtD
Fondaparinux sodium—Pruritus—Bleomycin—melanoma	0.00145	0.00173	CcSEcCtD
Fondaparinux sodium—Arrhythmia—Docetaxel—melanoma	0.00144	0.00172	CcSEcCtD
Fondaparinux sodium—Feeling abnormal—Temozolomide—melanoma	0.00142	0.0017	CcSEcCtD
Fondaparinux sodium—SERPINC1—Hemostasis—SPARC—melanoma	0.00141	0.00862	CbGpPWpGaD
Fondaparinux sodium—SERPINC1—Hemostasis—F2R—melanoma	0.00141	0.00862	CbGpPWpGaD
Fondaparinux sodium—Abdominal pain—Carmustine—melanoma	0.00141	0.00169	CcSEcCtD
Fondaparinux sodium—Body temperature increased—Carmustine—melanoma	0.00141	0.00169	CcSEcCtD
Fondaparinux sodium—Gastrointestinal pain—Temozolomide—melanoma	0.00141	0.00169	CcSEcCtD
Fondaparinux sodium—Malnutrition—Docetaxel—melanoma	0.0014	0.00168	CcSEcCtD
Fondaparinux sodium—Hypersensitivity—Dactinomycin—melanoma	0.0014	0.00168	CcSEcCtD
Fondaparinux sodium—Dysgeusia—Docetaxel—melanoma	0.00138	0.00164	CcSEcCtD
Fondaparinux sodium—Urticaria—Temozolomide—melanoma	0.00137	0.00164	CcSEcCtD
Fondaparinux sodium—Asthenia—Dactinomycin—melanoma	0.00137	0.00164	CcSEcCtD
Fondaparinux sodium—Abdominal pain—Temozolomide—melanoma	0.00136	0.00163	CcSEcCtD
Fondaparinux sodium—Body temperature increased—Temozolomide—melanoma	0.00136	0.00163	CcSEcCtD
Fondaparinux sodium—Back pain—Docetaxel—melanoma	0.00136	0.00162	CcSEcCtD
Fondaparinux sodium—F10—Metabolism of proteins—SLC17A5—melanoma	0.00133	0.00812	CbGpPWpGaD
Fondaparinux sodium—SERPINC1—Hemostasis—HSPA5—melanoma	0.00132	0.00807	CbGpPWpGaD
Fondaparinux sodium—Hypersensitivity—Carmustine—melanoma	0.00131	0.00157	CcSEcCtD
Fondaparinux sodium—Diarrhoea—Dactinomycin—melanoma	0.0013	0.00156	CcSEcCtD
Fondaparinux sodium—Vomiting—Bleomycin—melanoma	0.0013	0.00155	CcSEcCtD
Fondaparinux sodium—Anaemia—Docetaxel—melanoma	0.0013	0.00155	CcSEcCtD
Fondaparinux sodium—SERPINC1—Hemostasis—GNA11—melanoma	0.00129	0.00788	CbGpPWpGaD
Fondaparinux sodium—SERPINC1—Hemostasis—GAB2—melanoma	0.00129	0.00788	CbGpPWpGaD
Fondaparinux sodium—Rash—Bleomycin—melanoma	0.00129	0.00154	CcSEcCtD
Fondaparinux sodium—F10—Metabolism of proteins—ADAMTS13—melanoma	0.00129	0.00785	CbGpPWpGaD
Fondaparinux sodium—Dermatitis—Bleomycin—melanoma	0.00129	0.00154	CcSEcCtD
Fondaparinux sodium—Asthenia—Carmustine—melanoma	0.00128	0.00153	CcSEcCtD
Fondaparinux sodium—Hypersensitivity—Temozolomide—melanoma	0.00127	0.00152	CcSEcCtD
Fondaparinux sodium—Syncope—Docetaxel—melanoma	0.00126	0.00151	CcSEcCtD
Fondaparinux sodium—Palpitations—Docetaxel—melanoma	0.00124	0.00148	CcSEcCtD
Fondaparinux sodium—F10—Hemostasis—BSG—melanoma	0.00124	0.00756	CbGpPWpGaD
Fondaparinux sodium—Asthenia—Temozolomide—melanoma	0.00124	0.00148	CcSEcCtD
Fondaparinux sodium—Loss of consciousness—Docetaxel—melanoma	0.00123	0.00148	CcSEcCtD
Fondaparinux sodium—Cough—Docetaxel—melanoma	0.00123	0.00147	CcSEcCtD
Fondaparinux sodium—Diarrhoea—Carmustine—melanoma	0.00122	0.00146	CcSEcCtD
Fondaparinux sodium—Pruritus—Temozolomide—melanoma	0.00122	0.00146	CcSEcCtD
Fondaparinux sodium—Convulsion—Docetaxel—melanoma	0.00122	0.00146	CcSEcCtD
Fondaparinux sodium—SERPINC1—Hemostasis—HDAC2—melanoma	0.00122	0.00741	CbGpPWpGaD
Fondaparinux sodium—Nausea—Bleomycin—melanoma	0.00121	0.00145	CcSEcCtD
Fondaparinux sodium—Vomiting—Dactinomycin—melanoma	0.00121	0.00145	CcSEcCtD
Fondaparinux sodium—SERPINC1—Hemostasis—GNAQ—melanoma	0.0012	0.00733	CbGpPWpGaD
Fondaparinux sodium—SERPINC1—Hemostasis—CD44—melanoma	0.0012	0.00733	CbGpPWpGaD
Fondaparinux sodium—SERPINC1—Hemostasis—ITGA4—melanoma	0.0012	0.00733	CbGpPWpGaD
Fondaparinux sodium—Rash—Dactinomycin—melanoma	0.0012	0.00144	CcSEcCtD
Fondaparinux sodium—F10—Hemostasis—IFNA5—melanoma	0.0012	0.00732	CbGpPWpGaD
Fondaparinux sodium—Chest pain—Docetaxel—melanoma	0.0012	0.00143	CcSEcCtD
Fondaparinux sodium—SERPINC1—Hemostasis—IFNB1—melanoma	0.00119	0.00728	CbGpPWpGaD
Fondaparinux sodium—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—melanoma	0.00119	0.00142	CcSEcCtD
Fondaparinux sodium—Dizziness—Carmustine—melanoma	0.00118	0.00141	CcSEcCtD
Fondaparinux sodium—Diarrhoea—Temozolomide—melanoma	0.00118	0.00141	CcSEcCtD
Fondaparinux sodium—F10—Hemostasis—FLNA—melanoma	0.00117	0.00711	CbGpPWpGaD
Fondaparinux sodium—SERPINC1—Hemostasis—IFNA1—melanoma	0.00116	0.0071	CbGpPWpGaD
Fondaparinux sodium—Confusional state—Docetaxel—melanoma	0.00116	0.00138	CcSEcCtD
Fondaparinux sodium—Anaphylactic shock—Docetaxel—melanoma	0.00115	0.00137	CcSEcCtD
Fondaparinux sodium—Oedema—Docetaxel—melanoma	0.00115	0.00137	CcSEcCtD
Fondaparinux sodium—Dizziness—Temozolomide—melanoma	0.00114	0.00136	CcSEcCtD
Fondaparinux sodium—Infection—Docetaxel—melanoma	0.00114	0.00136	CcSEcCtD
Fondaparinux sodium—Vomiting—Carmustine—melanoma	0.00113	0.00136	CcSEcCtD
Fondaparinux sodium—Nausea—Dactinomycin—melanoma	0.00113	0.00135	CcSEcCtD
Fondaparinux sodium—SERPINC1—Hemostasis—SYK—melanoma	0.00113	0.00689	CbGpPWpGaD
Fondaparinux sodium—Shock—Docetaxel—melanoma	0.00113	0.00135	CcSEcCtD
Fondaparinux sodium—Rash—Carmustine—melanoma	0.00112	0.00135	CcSEcCtD
Fondaparinux sodium—Nervous system disorder—Docetaxel—melanoma	0.00112	0.00134	CcSEcCtD
Fondaparinux sodium—Dermatitis—Carmustine—melanoma	0.00112	0.00134	CcSEcCtD
Fondaparinux sodium—Thrombocytopenia—Docetaxel—melanoma	0.00112	0.00134	CcSEcCtD
Fondaparinux sodium—Tachycardia—Docetaxel—melanoma	0.00112	0.00134	CcSEcCtD
Fondaparinux sodium—Headache—Carmustine—melanoma	0.00112	0.00134	CcSEcCtD
Fondaparinux sodium—Skin disorder—Docetaxel—melanoma	0.00111	0.00133	CcSEcCtD
Fondaparinux sodium—SERPINC1—Hemostasis—ITGAV—melanoma	0.00111	0.00676	CbGpPWpGaD
Fondaparinux sodium—SERPINC1—Hemostasis—AKT3—melanoma	0.00111	0.00676	CbGpPWpGaD
Fondaparinux sodium—Vomiting—Temozolomide—melanoma	0.0011	0.00131	CcSEcCtD
Fondaparinux sodium—Anorexia—Docetaxel—melanoma	0.00109	0.00131	CcSEcCtD
Fondaparinux sodium—Rash—Temozolomide—melanoma	0.00109	0.0013	CcSEcCtD
Fondaparinux sodium—Dermatitis—Temozolomide—melanoma	0.00109	0.0013	CcSEcCtD
Fondaparinux sodium—SERPINC1—Hemostasis—IFNA2—melanoma	0.00108	0.00661	CbGpPWpGaD
Fondaparinux sodium—Headache—Temozolomide—melanoma	0.00108	0.00129	CcSEcCtD
Fondaparinux sodium—Hypotension—Docetaxel—melanoma	0.00107	0.00128	CcSEcCtD
Fondaparinux sodium—Nausea—Carmustine—melanoma	0.00106	0.00127	CcSEcCtD
Fondaparinux sodium—F10—Hemostasis—CLU—melanoma	0.00105	0.00643	CbGpPWpGaD
Fondaparinux sodium—Insomnia—Docetaxel—melanoma	0.00104	0.00124	CcSEcCtD
Fondaparinux sodium—F10—Hemostasis—RHOB—melanoma	0.00103	0.00629	CbGpPWpGaD
Fondaparinux sodium—Paraesthesia—Docetaxel—melanoma	0.00103	0.00123	CcSEcCtD
Fondaparinux sodium—Nausea—Temozolomide—melanoma	0.00102	0.00122	CcSEcCtD
Fondaparinux sodium—Dyspnoea—Docetaxel—melanoma	0.00102	0.00122	CcSEcCtD
Fondaparinux sodium—Somnolence—Docetaxel—melanoma	0.00102	0.00122	CcSEcCtD
Fondaparinux sodium—Dyspepsia—Docetaxel—melanoma	0.00101	0.00121	CcSEcCtD
Fondaparinux sodium—SERPINC1—Hemostasis—ITGB1—melanoma	0.00101	0.00614	CbGpPWpGaD
Fondaparinux sodium—Decreased appetite—Docetaxel—melanoma	0.000996	0.00119	CcSEcCtD
Fondaparinux sodium—Gastrointestinal disorder—Docetaxel—melanoma	0.000989	0.00118	CcSEcCtD
Fondaparinux sodium—Fatigue—Docetaxel—melanoma	0.000988	0.00118	CcSEcCtD
Fondaparinux sodium—Constipation—Docetaxel—melanoma	0.00098	0.00117	CcSEcCtD
Fondaparinux sodium—Pain—Docetaxel—melanoma	0.00098	0.00117	CcSEcCtD
Fondaparinux sodium—F10—Metabolism of proteins—RPS3—melanoma	0.00096	0.00585	CbGpPWpGaD
Fondaparinux sodium—Feeling abnormal—Docetaxel—melanoma	0.000944	0.00113	CcSEcCtD
Fondaparinux sodium—Gastrointestinal pain—Docetaxel—melanoma	0.000937	0.00112	CcSEcCtD
Fondaparinux sodium—F10—Hemostasis—RAC2—melanoma	0.000925	0.00564	CbGpPWpGaD
Fondaparinux sodium—SERPINC1—Hemostasis—HGF—melanoma	0.000922	0.00562	CbGpPWpGaD
Fondaparinux sodium—SERPINC1—Hemostasis—CSF2—melanoma	0.000911	0.00556	CbGpPWpGaD
Fondaparinux sodium—F10—Hemostasis—VEGFC—melanoma	0.00091	0.00555	CbGpPWpGaD
Fondaparinux sodium—Abdominal pain—Docetaxel—melanoma	0.000906	0.00108	CcSEcCtD
Fondaparinux sodium—Body temperature increased—Docetaxel—melanoma	0.000906	0.00108	CcSEcCtD
Fondaparinux sodium—SERPINC1—Hemostasis—ITGB3—melanoma	0.000874	0.00533	CbGpPWpGaD
Fondaparinux sodium—SERPINC1—Hemostasis—PRKCA—melanoma	0.000874	0.00533	CbGpPWpGaD
Fondaparinux sodium—Hypersensitivity—Docetaxel—melanoma	0.000844	0.00101	CcSEcCtD
Fondaparinux sodium—Asthenia—Docetaxel—melanoma	0.000822	0.000984	CcSEcCtD
Fondaparinux sodium—Pruritus—Docetaxel—melanoma	0.000811	0.00097	CcSEcCtD
Fondaparinux sodium—SERPINC1—Hemostasis—RAC1—melanoma	0.00081	0.00494	CbGpPWpGaD
Fondaparinux sodium—F10—Hemostasis—SPARC—melanoma	0.000799	0.00487	CbGpPWpGaD
Fondaparinux sodium—F10—Hemostasis—F2R—melanoma	0.000799	0.00487	CbGpPWpGaD
Fondaparinux sodium—Diarrhoea—Docetaxel—melanoma	0.000784	0.000938	CcSEcCtD
Fondaparinux sodium—SERPINC1—Hemostasis—MMP1—melanoma	0.000784	0.00478	CbGpPWpGaD
Fondaparinux sodium—SERPINC1—Hemostasis—CDK2—melanoma	0.000769	0.00469	CbGpPWpGaD
Fondaparinux sodium—Dizziness—Docetaxel—melanoma	0.000758	0.000907	CcSEcCtD
Fondaparinux sodium—F10—Hemostasis—HSPA5—melanoma	0.000748	0.00456	CbGpPWpGaD
Fondaparinux sodium—F10—Hemostasis—GAB2—melanoma	0.000731	0.00446	CbGpPWpGaD
Fondaparinux sodium—F10—Hemostasis—GNA11—melanoma	0.000731	0.00446	CbGpPWpGaD
Fondaparinux sodium—Vomiting—Docetaxel—melanoma	0.000729	0.000872	CcSEcCtD
Fondaparinux sodium—Rash—Docetaxel—melanoma	0.000723	0.000864	CcSEcCtD
Fondaparinux sodium—Dermatitis—Docetaxel—melanoma	0.000722	0.000864	CcSEcCtD
Fondaparinux sodium—Headache—Docetaxel—melanoma	0.000718	0.000859	CcSEcCtD
Fondaparinux sodium—SERPINC1—Hemostasis—FN1—melanoma	0.000715	0.00436	CbGpPWpGaD
Fondaparinux sodium—SERPINC1—Hemostasis—NOS2—melanoma	0.000707	0.00431	CbGpPWpGaD
Fondaparinux sodium—F10—Hemostasis—HDAC2—melanoma	0.000687	0.00419	CbGpPWpGaD
Fondaparinux sodium—SERPINC1—Hemostasis—PIK3CG—melanoma	0.000684	0.00417	CbGpPWpGaD
Fondaparinux sodium—Nausea—Docetaxel—melanoma	0.000681	0.000814	CcSEcCtD
Fondaparinux sodium—F10—Hemostasis—ITGA4—melanoma	0.000679	0.00414	CbGpPWpGaD
Fondaparinux sodium—F10—Hemostasis—CD44—melanoma	0.000679	0.00414	CbGpPWpGaD
Fondaparinux sodium—F10—Hemostasis—GNAQ—melanoma	0.000679	0.00414	CbGpPWpGaD
Fondaparinux sodium—SERPINC1—Hemostasis—EGF—melanoma	0.000676	0.00412	CbGpPWpGaD
Fondaparinux sodium—F10—Hemostasis—IFNB1—melanoma	0.000674	0.00411	CbGpPWpGaD
Fondaparinux sodium—F10—Hemostasis—IFNA1—melanoma	0.000658	0.00401	CbGpPWpGaD
Fondaparinux sodium—F10—Hemostasis—SYK—melanoma	0.000639	0.00389	CbGpPWpGaD
Fondaparinux sodium—F10—Hemostasis—ITGAV—melanoma	0.000627	0.00382	CbGpPWpGaD
Fondaparinux sodium—F10—Hemostasis—AKT3—melanoma	0.000627	0.00382	CbGpPWpGaD
Fondaparinux sodium—SERPINC1—Hemostasis—IGF1—melanoma	0.000627	0.00382	CbGpPWpGaD
Fondaparinux sodium—F10—Hemostasis—IFNA2—melanoma	0.000612	0.00373	CbGpPWpGaD
Fondaparinux sodium—F10—Metabolism of proteins—PAX6—melanoma	0.000612	0.00373	CbGpPWpGaD
Fondaparinux sodium—SERPINC1—Hemostasis—PIK3CD—melanoma	0.000602	0.00367	CbGpPWpGaD
Fondaparinux sodium—SERPINC1—Hemostasis—ALB—melanoma	0.000594	0.00362	CbGpPWpGaD
Fondaparinux sodium—F10—Metabolism of proteins—HSPA5—melanoma	0.000588	0.00359	CbGpPWpGaD
Fondaparinux sodium—F10—Hemostasis—ITGB1—melanoma	0.000569	0.00347	CbGpPWpGaD
Fondaparinux sodium—SERPINC1—Hemostasis—PIK3CB—melanoma	0.000524	0.0032	CbGpPWpGaD
Fondaparinux sodium—F10—Hemostasis—HGF—melanoma	0.000521	0.00317	CbGpPWpGaD
Fondaparinux sodium—F10—Hemostasis—CSF2—melanoma	0.000515	0.00314	CbGpPWpGaD
Fondaparinux sodium—F10—Hemostasis—ITGB3—melanoma	0.000494	0.00301	CbGpPWpGaD
Fondaparinux sodium—F10—Hemostasis—PRKCA—melanoma	0.000494	0.00301	CbGpPWpGaD
Fondaparinux sodium—SERPINC1—Hemostasis—IL2—melanoma	0.000482	0.00294	CbGpPWpGaD
Fondaparinux sodium—F10—Hemostasis—RAC1—melanoma	0.000458	0.00279	CbGpPWpGaD
Fondaparinux sodium—F10—Hemostasis—MMP1—melanoma	0.000443	0.0027	CbGpPWpGaD
Fondaparinux sodium—F10—Hemostasis—CDK2—melanoma	0.000435	0.00265	CbGpPWpGaD
Fondaparinux sodium—SERPINC1—Hemostasis—VEGFA—melanoma	0.000409	0.00249	CbGpPWpGaD
Fondaparinux sodium—SERPINC1—Hemostasis—NRAS—melanoma	0.000404	0.00246	CbGpPWpGaD
Fondaparinux sodium—F10—Hemostasis—FN1—melanoma	0.000404	0.00246	CbGpPWpGaD
Fondaparinux sodium—F10—Hemostasis—NOS2—melanoma	0.000399	0.00243	CbGpPWpGaD
Fondaparinux sodium—SERPINC1—Hemostasis—MAPK3—melanoma	0.000387	0.00236	CbGpPWpGaD
Fondaparinux sodium—F10—Hemostasis—PIK3CG—melanoma	0.000387	0.00236	CbGpPWpGaD
Fondaparinux sodium—F10—Hemostasis—EGF—melanoma	0.000382	0.00233	CbGpPWpGaD
Fondaparinux sodium—SERPINC1—Hemostasis—MAPK1—melanoma	0.000368	0.00225	CbGpPWpGaD
Fondaparinux sodium—F10—Hemostasis—IGF1—melanoma	0.000354	0.00216	CbGpPWpGaD
Fondaparinux sodium—F10—Metabolism of proteins—MMP1—melanoma	0.000348	0.00212	CbGpPWpGaD
Fondaparinux sodium—SERPINC1—Hemostasis—KRAS—melanoma	0.000348	0.00212	CbGpPWpGaD
Fondaparinux sodium—F10—Hemostasis—PIK3CD—melanoma	0.00034	0.00207	CbGpPWpGaD
Fondaparinux sodium—F10—Hemostasis—ALB—melanoma	0.000336	0.00205	CbGpPWpGaD
Fondaparinux sodium—SERPINC1—Hemostasis—PIK3CA—melanoma	0.00032	0.00195	CbGpPWpGaD
Fondaparinux sodium—SERPINC1—Hemostasis—TP53—melanoma	0.000309	0.00189	CbGpPWpGaD
Fondaparinux sodium—F10—Hemostasis—PIK3CB—melanoma	0.000296	0.00181	CbGpPWpGaD
Fondaparinux sodium—SERPINC1—Hemostasis—HRAS—melanoma	0.000296	0.0018	CbGpPWpGaD
Fondaparinux sodium—F10—Metabolism of proteins—IGF1—melanoma	0.000279	0.0017	CbGpPWpGaD
Fondaparinux sodium—F10—Hemostasis—IL2—melanoma	0.000272	0.00166	CbGpPWpGaD
Fondaparinux sodium—F10—Metabolism of proteins—MMP2—melanoma	0.00027	0.00164	CbGpPWpGaD
Fondaparinux sodium—SERPINC1—Hemostasis—AKT1—melanoma	0.000261	0.00159	CbGpPWpGaD
Fondaparinux sodium—F10—Hemostasis—VEGFA—melanoma	0.000231	0.00141	CbGpPWpGaD
Fondaparinux sodium—F10—Hemostasis—NRAS—melanoma	0.000228	0.00139	CbGpPWpGaD
Fondaparinux sodium—F10—Metabolism of proteins—CXCL8—melanoma	0.000224	0.00137	CbGpPWpGaD
Fondaparinux sodium—F10—Hemostasis—MAPK3—melanoma	0.000219	0.00133	CbGpPWpGaD
Fondaparinux sodium—F10—Hemostasis—MAPK1—melanoma	0.000208	0.00127	CbGpPWpGaD
Fondaparinux sodium—F10—Metabolism of proteins—CTNNB1—melanoma	0.000207	0.00126	CbGpPWpGaD
Fondaparinux sodium—F10—Hemostasis—KRAS—melanoma	0.000197	0.0012	CbGpPWpGaD
Fondaparinux sodium—F10—Hemostasis—PIK3CA—melanoma	0.000181	0.0011	CbGpPWpGaD
Fondaparinux sodium—F10—Hemostasis—TP53—melanoma	0.000175	0.00107	CbGpPWpGaD
Fondaparinux sodium—F10—Hemostasis—HRAS—melanoma	0.000167	0.00102	CbGpPWpGaD
Fondaparinux sodium—F10—Hemostasis—AKT1—melanoma	0.000148	0.0009	CbGpPWpGaD
